In this episode, we talk not about the business side of Novo Nordisk, but zoom in on the science that we didn't really do as much in the episode
Heat shock proteins and exercise adaptations
Choi_ Nikolai stock.adobe.com News Weight loss and diabetes medication GLP-1 agonists may interfere with cancer imaging, new study finds The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed. GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023
GHRP2 users often report improved sleep quality and more vivid dreams, likely due to enhanced REM-NREM cycling
At Fitty , we are here to support women who are navigating weight loss during PMDD by helping manage cravings and appetite
The idea of being on medication indefinitely might not sit well with you
